RxDoctor Payments Data

Leland Dampier, MD

Family Medicine · Savannah, GANPI 1821388893

Payments from drug & device makers

$8,679in general payments, 2019–2025

Across 595 payments — averaging $14.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$994
  • Novartis$968
  • Amgen$879
  • AstraZeneca$787
  • Lilly USA, LLC$630
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$8,640100%
  • Education$390%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,679 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$275,011
Medicare patients
722
Services billed
5,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide166$176,837
JardianceEmpagliflozin116$136,726
EliquisApixaban85$94,653
JanuviaSitagliptin Phosphate48$61,914
FarxigaDapagliflozin Propanediol62$58,658
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$30,668
EntrestoSacubitril/Valsartan19$29,270
TrulicityDulaglutide28$26,139
MounjaroTirzepatide20$25,060
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr37$20,918
MyrbetriqMirabegron14$18,560
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog55$17,267
Tresiba Flextouch U-100Insulin Degludec37$16,566
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$14,070
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog31$13,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog Mix 70-30$1,120$179,269182 claims
Boehringer IngelheimJardiance, Glyxambi$247$148,740136 claims
PfizerEliquis$436$94,65385 claims
AstraZenecaFarxiga, Breztri Aerosphere$787$72,72876 claims
MerckJanuvia$236$61,91448 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$300$57,76690 claims
Lilly USA, LLCTrulicity, Mounjaro$630$51,19848 claims
NovartisEntresto$968$29,27019 claims
Astellas Pharma US IncMyrbetriq$60$18,56014 claims
AbbVieLinzess$994$13,14716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →